| Michael A. Metzger | Chief Executive Officer | FY2025 | |
| Nick Botwood, M.B.B.S. | Head of Research & Development, Chief Medical Officer | FY2025 | |
| Keith A. Goldan | Chief Financial Officer | FY2025 | |
| Luke J. Albrecht | General Counsel and Secretary | FY2025 | |
| Steve Closter | Chief Commercial Officer | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.